PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma

Multiple myeloma (MM) is a devastating cancer with a highly heterogeneous outcome. Because of the heterogeneity of myeloma cells, risk stratification is important for making therapeutic regimens. Nevertheless, no immunohistochemical predictive and prognostic marker has been constructed yet. In the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Hua, Zhu, Yudi, Xu, Peipei, Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303762/
https://www.ncbi.nlm.nih.gov/pubmed/32596309
http://dx.doi.org/10.1155/2020/4286101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303762/
https://www.ncbi.nlm.nih.gov/pubmed/32596309
http://dx.doi.org/10.1155/2020/4286101

Ejemplares similares